Business Context and Reporting Period
Company: Hyperion DeFi, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 5, 2026
Event: Entry into an underwriting agreement for a public offering of common stock.
Key Financial Metrics and Offering Details
- Shares Issued: 2,777,778 shares of Common Stock.
- Offering Price: $3.60 per share.
- Underwriter Purchase Price: $3.384 per share.
- Over-Allotment Option: 30-day option to purchase up to 416,666 additional shares.
- Expected Net Proceeds: Approximately $8.7 million (base); approximately $10.1 million if the over-allotment option is fully exercised.
- Underwriter: Chardan Capital Markets, LLC.
- Expected Closing Date: May 7, 2026.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses solely on the capital raise transaction.
Material Changes and Transaction Structure
The Company entered into an underwriting agreement to raise capital via a registered offering under a shelf registration statement (Form S-3 No. 333-291570) declared effective on December 9, 2025. The transaction involves the sale of new shares, which will increase the Company's equity capital upon closing.
Guidance, Outlook, and Risks
- Use of Proceeds: The filing references anticipated use of proceeds but does not detail specific allocation in the text provided; investors should refer to the accompanying prospectus supplement.
- Forward-Looking Statements: The Company cautions that actual results may differ due to market conditions and customary closing conditions.
- Risks: Risks are referenced as described in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
- Legal Opinion: Latham & Watkins LLP provided an opinion on the legality of the issuance.
Investor Verification Checklist
- Verify the final closing date and whether the over-allotment option was exercised.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and termination provisions.
- Consult the Prospectus Supplement for the detailed "Use of Proceeds" and updated risk factors.
- Check the Company's most recent Form 10-K (fiscal year ended Dec 31, 2025) for baseline financial health and existing debt obligations.
- Confirm the post-offering share count and potential dilution impact on existing shareholders.